Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fe-ASP versus ferrous sulfate for iron deficiency anemia
2017-002972-15Phase 4Completed
- Sponsor
- Uni-Pharma
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Iron protein acetyl aspartilate arm with Ferrous sulfate arm (2 arms). Primary endpoint: Hemoglobin increase from baseline at 4 weeks adjusted for elemental iron dose. Started Sep 2017; status: completed.
02
Drugs
iron protein acetylaspartateferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2017-002972-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002972-15.